[ad_1] Eisai and Biogen announced that patients with early Alzheimer's disease who received the highest dose of experimental drug BAN2401 experienced a 30% decline in clinical decline compared to placebo at 18 …
Read More »Alzheimer's, positive results for a drug experimented by Biogen
[ad_1] The World Alzheimer's Report of 2017 estimates that 47 million people with dementia worldwide with strong growth expected in the coming years due to the increase in average age: the forecast …
Read More »